1720 related articles for article (PubMed ID: 27912844)
1. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
2. Heparanase and cancer progression: New directions, new promises.
Arvatz G; Weissmann M; Ilan N; Vlodavsky I
Hum Vaccin Immunother; 2016 Sep; 12(9):2253-6. PubMed ID: 27054564
[TBL] [Abstract][Full Text] [Related]
3. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.
Sanderson RD; Elkin M; Rapraeger AC; Ilan N; Vlodavsky I
FEBS J; 2017 Jan; 284(1):42-55. PubMed ID: 27758044
[TBL] [Abstract][Full Text] [Related]
4. Heparanase-A single protein with multiple enzymatic and nonenzymatic functions.
Vlodavsky I; Kayal Y; Hilwi M; Soboh S; Sanderson RD; Ilan N
Proteoglycan Res; 2023 Jul; 1(3):e6. PubMed ID: 37547889
[TBL] [Abstract][Full Text] [Related]
5. Role of heparanase in tumor progression: Molecular aspects and therapeutic options.
Masola V; Zaza G; Gambaro G; Franchi M; Onisto M
Semin Cancer Biol; 2020 May; 62():86-98. PubMed ID: 31348993
[TBL] [Abstract][Full Text] [Related]
6. Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.
Vlodavsky I; Gross-Cohen M; Weissmann M; Ilan N; Sanderson RD
Trends Biochem Sci; 2018 Jan; 43(1):18-31. PubMed ID: 29162390
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.
Bandari SK; Purushothaman A; Ramani VC; Brinkley GJ; Chandrashekar DS; Varambally S; Mobley JA; Zhang Y; Brown EE; Vlodavsky I; Sanderson RD
Matrix Biol; 2018 Jan; 65():104-118. PubMed ID: 28888912
[TBL] [Abstract][Full Text] [Related]
8. Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.
Weissmann M; Arvatz G; Horowitz N; Feld S; Naroditsky I; Zhang Y; Ng M; Hammond E; Nevo E; Vlodavsky I; Ilan N
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):704-9. PubMed ID: 26729870
[TBL] [Abstract][Full Text] [Related]
9. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
10. Significance of host heparanase in promoting tumor growth and metastasis.
Zhang GL; Gutter-Kapon L; Ilan N; Batool T; Singh K; Digre A; Luo Z; Sandler S; Shaked Y; Sanderson RD; Wang XM; Li JP; Vlodavsky I
Matrix Biol; 2020 Nov; 93():25-42. PubMed ID: 32534153
[TBL] [Abstract][Full Text] [Related]
11. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
12. Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.
Ramani VC; Zhan F; He J; Barbieri P; Noseda A; Tricot G; Sanderson RD
Oncotarget; 2016 Jan; 7(2):1598-607. PubMed ID: 26624982
[TBL] [Abstract][Full Text] [Related]
13. Development of heparanase inhibitors for anti-cancer therapy.
Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications.
Barash U; Lapidot M; Zohar Y; Loomis C; Moreira A; Feld S; Goparaju C; Yang H; Hammond E; Zhang G; Li JP; Ilan N; Nagler A; Pass HI; Vlodavsky I
J Natl Cancer Inst; 2018 Oct; 110(10):1102-1114. PubMed ID: 29579286
[TBL] [Abstract][Full Text] [Related]
15. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
[TBL] [Abstract][Full Text] [Related]
16. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
17. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.
Yang Y; Macleod V; Miao HQ; Theus A; Zhan F; Shaughnessy JD; Sawyer J; Li JP; Zcharia E; Vlodavsky I; Sanderson RD
J Biol Chem; 2007 May; 282(18):13326-33. PubMed ID: 17347152
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
19. The potential of heparanase as a therapeutic target in cancer.
Pisano C; Vlodavsky I; Ilan N; Zunino F
Biochem Pharmacol; 2014 May; 89(1):12-9. PubMed ID: 24565907
[TBL] [Abstract][Full Text] [Related]
20. The impact of heparanese and heparin on cancer metastasis and angiogenesis.
Vlodavsky I; Abboud-Jarrous G; Elkin M; Naggi A; Casu B; Sasisekharan R; Ilan N
Pathophysiol Haemost Thromb; 2006; 35(1-2):116-27. PubMed ID: 16855356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]